Strategies for improvement of awareness, treatment and control of hypertension: Results of a panel discussion

Journal of Human Hypertension

Volumn 18, Issue 8, 2004, Pages 563-565

  Whelton, P K ^a,d   Beevers, D G ^b   Sonkodi, S ^c  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Department of Health Sciences ^*  (United States)

Author keywords

Blood pressure; Epidemiology

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; AWARENESS; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH SURVEY; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIFESTYLE; MEDICAL SOCIETY; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SAMPLING; STROKE; SYMPOSIUM; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; AWARENESS; HUMANS; HYPERTENSION;

EID: 4444378933     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001738     Document Type: Review

References (16)

1. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks US population data. Arch Intern Med 1993; 153: 598-615.
2. Klag MJ et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
3. Haider AW et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10-16.
4. Young JH et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002; 13: 2776-2782.
5. Kearney PM WM, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-19.
6. Dzerve VBN et al. Prevalence and control of hypertension in Latvia. J Hum Hypertens 2004, in press.
7. Zdrojewski TSP et al. Arterial hypertension in Poland in 2002. J Hum Hypertens 2004, in press.
8. Cifkova RSZ et al. Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997-98 and 2000/01, Czech Post-MONICA. J Hum Hypertens 2004, in press.
9. Burt VL et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
10. Ibrahim MM et al. Cardiovascular risk factors in normotensive and hypertensive Egyptians. J Hypertens. 2001; 19: 1933-1940.
11. Gu D et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40: 920-927.
12. Muntner PGD et al. For the InterASIA Collaborative Group. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension 2004; 43: 1-8.
13. Barker WH, Mullooly JP, Linton KL. Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension 1998; 31(1 Pt 2): 552-559.
14. Berlowitz DR et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-1963.
15. Lloyd-Jones DM, Evans JC, Larson MG, Levy D. Treatment and control of hypertension in the community: a prospective analysis. Hypertension 2002; 40: 640-646.
16. He J et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162: 1051-1058.